Zealand Pharma

Did you know that congenital hyperinsulinism (CHI) is the most frequent cause of severe, persistent hypoglycemia in newborn babies & children? Or that, in most countries, CHI occurs in about 1 in 28,000 - 1 in 50,000 births?⤵️Learn more about this rare disease Want to know more? Visit Congenital Hyperinsulinism International on for updates and on their website for more information on CHI

From our start in 1998, Zealand Pharma has been dedicated to the discovery, design, and development of innovative peptide-based medicines.   Now, 300+ employees and 26 years later, our purpose is still the same: to change lives with next-generation peptide therapeutics.   As we celebrate our 26th year and look forward to the future, we would like to thank the dedicated Zealanders who have contributed to the company’s progress, the patients and their caregivers who have taken part in our clinical trials, and our partners and shareholders for their continued support. #withZEAL

A few of us at Zealand had the chance to end September in the sweetest way by attending the 11th Annual Sugar Soiree hosted by Congenital Hyperinsulinism International. This event, once again, brought together supporters to celebrate the congenital hyperinsulinism (HI) community and to raise funds to improve the lives of children and adults born with this rare condition.   It was a fantastic night hosted by Cheri Preston, an ABC news radio and podcast anchor, and featuring a variety of special guest speakers who work closely or live with HI every day. Thank you to Julie Raskin, Jennifer Jervis Schmitt, all of CHI International for putting this event together and for all your hard work to make a difference in the lives of people living with Congenital Hyperinsulinism, their families and caregivers, and the doctors and nurses that support them. We look forward to continuing to work alongside the CHI community.   #withZeal (in the photo from Left to Right the Zealand team included: Nancy Hunter, Jelena Ivkovic, Taylor Bourne, Chandra Slusser, and Theis Gondolf - and not pictured Camilla Westergaard Borgen)

Congratulations to David Baker, Demis Hassabis, and John M. Jumper on being awarded the 2024 Nobel Prize in Chemistry. Their work is already contributing every day to help companies like Zealand Pharma discover and design peptides that could one day be used to develop new treatments for people who need them. Learn more about the science behind this year's Nobel Prize in Chemistry: Press release: https://lnkd.in/eknNuN4C Popular information: https://lnkd.in/dtReFeYp Advanced information: 

Yesterday, Brad Loncar, founder of BiotechTV, stopped by our office outside Copenhagen to talk to our CEO, Adam Steensberg,. They discussed different approaches to treating obesity and the R&D work that we are doing here at Zealand. Check out the clip below or watch the full video here: https://lnkd.in/eHR9H2Tj

Today we are attending the Career Day at the Faculty of Health and Medical Sciences at Københavns Universitet - University of Copenhagen.    Come by our stand and learn more about the Zealand Pharma culture, our career opportunities, and how you can join us on our mission to change lives with next-generation peptide therapeutics. #withZEAL

Did you see Zealand Pharma at the European Association for the Study of Diabetes e.V. (EASD)'s 60th Annual Meeting? Two weeks ago, Dan Hesse, Bill Vestergaard, Stanislava Macura, Stine Just Maarbjerg, Patrick Boiken, and Jesper Mosolff Mathiesen met up in Madrid for 5 days of insights from some of the best in the industry. At the conference, this talented group:   ⭐Participated in a variety of meetings ⭐Engaged in informative scientific talks ⭐Learned from presentations about the latest industry data and trends ⭐And got to watch our very own Bill share 2 presentations!   Thank you EASD for a successful 5 days surrounded by industry experts, knowledge, and great company

What does it take to change lives with next-generation peptide therapeutics? A whole bunch of skilled and motivated employees! 💡🧠 Our employees are the center of our mission to change lives with next generation peptide therapeutics. So, as Zealand Pharma grows, we need even more ambitious employees to help us make a difference for people living with unmet medical needs. See our current open positions: https://lnkd.in/dnwgKwak

From September 7 – 10, Zealanders Mark Berner Hansen, Per-Olof F Eriksson, and Lise Soldbro represented Zealand Pharma at the 46th Annual ESPEN - European Society for Clinical Nutrition and Metabolism Congress in Milan, Italy. Each year, ESPEN holds a congress to bring together thousands of participants from around the world to discuss and learn about research and clinical advancements in the nutrition and metabolism space. This year, our team had the opportunity to:   ⭐ learn from a variety of presentations ⭐ engage in exciting poster sessions ⭐ participate in community events ⭐ and of course see a bit of Milan   Thank you to ESPEN for putting on such an insightful and informative congress every year. We can’t wait to see you next year in Prague!

This week, we celebrated our annual🥧🍎 Apple Pie Day! 🥧🍎 Early in the morning, a bunch of Zealanders gathered to peel and chop apples to make more than 15 apple pies. 👩🍳   Freshly baked desserts were enjoyed by our colleagues that afternoon. This Zealand tradition dates back to our previous office where we baked apple pies from the fruit that fell from the trees in our garden. Looking forward to next year's baking already! #withZEAL